Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications that were first approved to lower blood sugar in people with type 2 diabetes. Eventually, researchers discovered that these ...
Small businesses are investing in artificial intelligence at record rates, but workers have mixed feelings about the pace of change. Small and mid-sized businesses (SMB) have crossed a pivotal ...